CLINICAL_TRIALS
trial_result
· 2017-03-15
Clinical Trial Update: Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease [Phase 2]
Summary
Phase 2 trial evaluating pentostatin for refractory chronic graft-versus-host disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-03-15